{"url":"https://lda.gov/api/v1/filings/28f77d11-2434-48dd-9e46-7b29257d3d0e/","filing_uuid":"28f77d11-2434-48dd-9e46-7b29257d3d0e","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2025,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/28f77d11-2434-48dd-9e46-7b29257d3d0e/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"William Minor, Partner","dt_posted":"2025-04-21T16:39:41-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"500 8th Street, NW","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":76855,"url":"https://lda.gov/api/v1/registrants/76855/","house_registrant_id":32113,"name":"DLA PIPER LLP (US)","description":"Law firm.","address_1":"500 8th Street, NW","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"WILLIAM MINOR","contact_telephone":"+1 202-799-4312","dt_updated":"2026-07-30T08:35:35.415773-04:00"},"client":{"id":53491,"url":"https://lda.gov/api/v1/clients/53491/","client_id":53491,"name":"BIOHAVEN PHARMACEUTICALS, INC.","general_description":"A biopharmaceutical company.","client_government_entity":null,"client_self_select":false,"state":"CT","state_display":"Connecticut","country":"US","country_display":"United States of America","ppb_state":"CT","ppb_state_display":"Connecticut","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-11-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Policies related to drug approval for treatment of rare diseases. Policies related to exclusivity of small molecule drugs. Regulatory flexibilities afforded to neurodegenerative diseases as provided for in the Act of ALS.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":139175,"prefix":"mr","prefix_display":"MR.","first_name":"JAMIE","nickname":null,"middle_name":"ALEXEI","last_name":"GREGORIAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101694,"prefix":null,"prefix_display":null,"first_name":"ALEX","nickname":null,"middle_name":null,"last_name":"PINSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147290,"prefix":null,"prefix_display":null,"first_name":"KARINA","nickname":null,"middle_name":null,"last_name":"LYNCH","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":149501,"prefix":null,"prefix_display":null,"first_name":"VINCENT","nickname":null,"middle_name":null,"last_name":"SARUBBI","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff and Legislative Director, Rep. Josh Gottheimer; Legis. Assistant, Sen. Sherrod Brown; Senior Legislative Assistant, Rep. Donald Norcross; Legislative Assistant, Rep. Rob Andrews","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}